ENO1 and neoplasm: When we observed that KPC/IL17A−/− tumours were much more infiltrated by CD8+ T cells and significantly less by Treg,9 we thought to exploit the TME reshaping mediated by the IL17A's depletion to improve the ENO1‐DNA vaccine efficacy.